ApprovalTrail

Approval · Notice of Compliance 5330 · 1994

AVIRAX: Notice of Compliance 5330

Issued March 10, 1994

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5330
Date
March 10, 1994
Company
Fabrigen Inc.Pierrefonds, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Antiviral agent

Products in this notice

BrandDINStatus today
AVIRAX02078465—
AVIRAX02078627Cancelled Post Market
AVIRAX02078635Cancelled Post Market
AVIRAX02078651Cancelled Post Market
AVIRAX02078643—
AVIRAX02078503—
AVIRAX02078473—
AVIRAX02078481—

Medicinal ingredients